Radiation for Pituitary Tumours — When It Is Needed, and What Follows

When Is Radiation Needed After Pituitary Surgery?

Not routinely. Radiation is usually added when the operation could not remove everything, when a leftover piece starts growing again, or when a hormone-producing tumour keeps overproducing despite surgery and medication. It is a second step, decided by your post-operative scan and your blood results, not by the diagnosis itself.

Most pituitary tumours are benign. Surgery through the nose, medication under an endocrinologist, and plain observation between scans handle the majority of them. So the first useful question is not which radiation technique — it is why radiation, and why now. There is almost always a specific trigger, and you are entitled to hear it named.

1. Tumour was deliberately left behind. Surgeons often stop short of a remnant wrapped around the carotid artery or tucked into the cavernous sinus, because taking the last few millimetres out would risk more than it gains. Focused radiation is the standard way of dealing with what remains.
2. The remnant is growing on follow-up scans. Two MRIs a year or so apart showing a measurable increase carry far more weight than one scan and an opinion. Documented growth is the most common reason radiation moves from possible to advised.
3. Hormone levels stay high after surgery. In tumours that overproduce a hormone, blood results that will not normalise despite an operation and medical treatment are a recognised reason to add radiation to the plan.
4. The tumour has already come back. Regrowth at the same site after an operation is a standard trigger, particularly when a second operation would be harder than the first.
5. The pathology report describes an aggressive tumour. Certain features on the tissue examined after surgery point to a tumour more likely to recur, and radiation may be recommended earlier because of them.

If none of those five applies to you, ask what would happen if you rescanned in six months instead. Waiting and watching is a legitimate answer for a benign, stable, symptom-free remnant, and it keeps radiation available for later.

When treatment is the right answer, your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout — including the endocrine and imaging follow-up that runs for years afterwards.

What Hormone Effects Follow Radiation to the Pituitary?

The important ones arrive late. Radiation gradually reduces the gland's own output, so new hormone deficiencies commonly appear years after treatment rather than during it. This is called hypopituitarism. Every deficiency is treatable with replacement — but replacement only starts if somebody is still testing you.

This is the part of the conversation that most often gets skipped, because it is not a side effect you feel in the treatment room. During the course itself most people notice tiredness and little else. The consequence that actually changes daily life turns up eighteen months, five years or a decade later, quietly, disguised as fatigue or low mood. Knowing to expect it is what turns it from a mystery illness into a blood test and a prescription.

Deficiencies can begin to appear from roughly a year after treatment and continue to appear over a decade or more. The risk relates to the dose the normal gland receives and to how long ago you were treated, which is precisely why endocrine follow-up guidance from bodies such as ESMO and NCCN, current as of August 2026, describes indefinite testing rather than a fixed discharge date.

Two things are worth separating out. Constant thirst with passing large volumes of urine is far more often a consequence of the operation than of the radiation. And in tumours that overproduce a hormone, the level falls gradually over months and years rather than immediately, so any medication you are on is usually continued and reduced only when the results allow it. Replacement and reduction are both handled by your endocrinologist, on the basis of your blood results.

Will Radiation Near the Pituitary Damage My Sight?

Nobody can promise you it will not, and be wary of anyone who does. What a team can do is calculate the dose your optic nerves and chiasm will receive, keep it below accepted constraints, spread the course out where the tumour touches the chiasm, and test your visual fields before and after so that any change is caught early.

Dose constraints for the optic pathway described by bodies such as ASTRO and NCCN, current as of August 2026, exist because the chiasm, not the tumour, is usually the limiting structure in this part of the head. Those constraints are the reason a plan takes days to build, the reason a medical physicist checks it independently, and the reason a single high-dose session is sometimes ruled out in favour of a longer course.

Tell your team at the planning appointment if you have useful sight in one eye only, existing glaucoma, retinal disease or previous radiation to the head. Each of those changes what the plan is willing to accept, and each should be written into the record before the planning scan is taken, not discovered afterwards.

Single-Session Radiosurgery or a Fractionated Course?

Distance from the optic chiasm usually decides it. Where there is a clear gap between the tumour and the chiasm, a single focused session may be possible. Where the tumour is touching or pressing on it, the dose is spread over several weeks instead, because the optic pathway tolerates it far better that way.

If you have been offered one and not the other, ask why. The answer is nearly always the distance from your optic chiasm on the planning scan, and it is a safety decision rather than a scheduling one.

What Surveillance Will I Need Afterwards, and For How Long?

For life. A pituitary hormone blood profile with a clinical review at set intervals, an MRI at intervals that widen over the years, and formal visual fields where the tumour sits near the optic pathway. Follow-up does not stop at five years, because new deficiencies keep appearing after that.

1. Before treatment, get a full baseline. A complete pituitary hormone profile, formal visual fields and acuity, and the planning MRI. Everything measured later is compared against this set, so an incomplete baseline weakens the next twenty years of follow-up.
2. The first year. Clinical review with blood tests at intervals your endocrinologist sets, and repeat visual fields if vision was involved at diagnosis. An MRI is usually taken at around the twelve-month mark to establish the new reference appearance.
3. Years two to five. Hormone testing continues at least yearly. MRI intervals widen if the tumour is stable. In overproducing tumours, the specific hormone level is tracked, because it declines gradually rather than all at once.
4. Beyond five years, keep going. This is where pituitary follow-up differs from most cancer follow-up. Deficiencies emerging at eight or twelve years are recognised and expected, so annual bloods should continue indefinitely rather than tailing off.
5. Know what brings you back early. Any new or worsening visual change, double vision, a persistent new headache unlike your usual one, unusual and unexplained exhaustion, or feeling disproportionately unwell during a simple illness. Do not wait for the next scheduled appointment.
6. Make sure one clinic holds the file. Scans, endocrine results and eye tests read together tell a story; read separately in three different places they tell nothing. Ask who is holding the whole picture and get that name written down.

If you were treated years ago and nobody has checked your hormones since, that is worth correcting rather than worrying about. A single blood profile and a review is a reasonable place to restart, and it is the most useful appointment many long-term patients never make.

What Actually Happens If Radiation Is Chosen?

Almost all of the effort goes into planning rather than treatment. A thin-slice MRI and a planning CT are fused, the tumour, the normal gland and the optic pathway are outlined by hand, and a medical physicist independently checks the dose to each structure before a single beam is switched on.

1. Joint discussion. A radiation oncologist, an endocrinologist, a neurosurgeon and a radiologist review your scans and blood results together and agree why radiation is being added now, and what the alternative was.
2. Baseline testing. Full pituitary hormone profile, formal visual fields and acuity. These are the numbers every later result is measured against, so it is worth chasing them if any are missing.
3. Immobilisation. A custom thermoplastic mask, or a rigid frame for a single session. It is snug rather than painful, and it is what allows the beam to be aimed to within about a millimetre.
4. Imaging and planning. MRI and CT with the mask or frame in place, then hours of careful outlining and dose checking. This is the part that takes days, and it is the part that protects your vision.
5. Treatment. You lie still and feel nothing at all. A fractionated course is a short daily appointment over several weeks; a single session is longer on the day but done once.
6. The first weeks. Tiredness is the usual complaint, sometimes a mild headache or slight hair thinning where the beams enter. Report any new visual change or unusual exhaustion straight away rather than waiting.
7. Long-term follow-up. MRI, visual fields and a hormone profile at agreed intervals, continuing for life. Stability on scans and deficiencies caught early are what a good long-term result looks like.

Costs vary by centre, by platform and by how complex the plan is, and a fractionated course is priced differently from a single session. Ask for a written estimate that names what is included, particularly the planning imaging and the years of follow-up tests. Any figure quoted is indicative only, as of August 2026.

Focused treatment for pituitary targets is delivered on linear-accelerator or dedicated radiosurgery platforms depending on the partner centre. CION Cancer Clinics does not own or operate any of that equipment and is not itself NABH-accredited. Your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout. If you are comparing centres, ask how many skull-base and pituitary plans they build each year, who independently checks them, and who will hold your endocrine follow-up afterwards.

The Questions People Ask Straight After This One

Treatment aimed anywhere near the eye and the skull base raises a predictable set of follow-up worries. These pages take them in turn, in the same plain order.

• Radiation for Orbital Lymphoma and Thyroid Eye Disease — low-dose treatment aimed inside the eye socket, for two conditions that are not always cancer.
• Dry Eye, Watering and Eyelid Changes After Orbital Radiation — the everyday comfort problems near the eye, and what genuinely helps.
• Plaque Brachytherapy for Ocular Melanoma — how radiation is delivered from a small plaque stitched to the eye rather than from a machine.
• Radiation for Retinoblastoma in Children — when radiation is used in a child's eye, and how the long-term follow-up is arranged.

If you would rather start from the beginning, Radiation Therapy at CION Cancer Clinics explains how a course is planned, where it is delivered and who looks after you throughout it.

People Who Wanted the Long-Term Picture First

Patients referred for a benign pituitary tumour who wanted the hormone and vision follow-up explained before agreeing to anything.